Preview

Pharmacogenetics and Pharmacogenomics

Advanced search

Оценка влияния полиморфизма гена MDR1 на эффективность ферротерапии у пациентов с железодефицитной анемией

https://doi.org/10.37489/2588-0527-2020-2-10-11

About the Authors

И. Мавлянов
Ташкентский институт усовершенствования врачей
Uzbekistan


Г. Жарылкасынова
Бухарский Государственный медицинский институт
Uzbekistan


Р. Юлдашова
Бухарский Государственный медицинский институт
Uzbekistan


References

1. Kassebaum NJ, Fleming TD, Flaxman A et al. The global burden of anemia. Hematol Oncol Clin North Am. 2016;30(2):247-308. doi: 10.1016/j.hoc.2015.11.002.

2. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011;4(3):177-184. DOI: 10.1177/1756283X11398736.

3. Zhumabayeva TN, Bazarbayeva SK, Zhilkibayeva BZh. General practice doctor’s role in diacrisis and curing of congestive heart failu. West Kazakhstan Medical journal. 2014;43(3):47-50. (In Russ).

4. Bailey RL, West KP, Black RE. The epidemiology of global micronutrient deficiencies. Ann Nutr Metab. 2015;66(2):22-33. DOI: 10.1159/000371618.

5. Armstrong GR, Summerlee AJ. The Etiology, Treatment and Effective Prevention of Iron Deficiency and Iron Deficiency Anemia in Women and Young Children Worldwide: A Review. J of Women`s Health Care. 2015;4:1. DOI: 10.4172/2167-0420.1000213.


Review

For citations:


 ,  ,   . Pharmacogenetics and Pharmacogenomics. 2020;(2):10-11. (In Russ.) https://doi.org/10.37489/2588-0527-2020-2-10-11

Views: 587


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2588-0527 (Print)
ISSN 2686-8849 (Online)